PH15031A - N-(tetrazol-5-yl)prostaglandin carboxamides - Google Patents

N-(tetrazol-5-yl)prostaglandin carboxamides

Info

Publication number
PH15031A
PH15031A PH22056A PH22056A PH15031A PH 15031 A PH15031 A PH 15031A PH 22056 A PH22056 A PH 22056A PH 22056 A PH22056 A PH 22056A PH 15031 A PH15031 A PH 15031A
Authority
PH
Philippines
Prior art keywords
tetrazol
carboxamides
prostaglandin
prostaglandin carboxamides
Prior art date
Application number
PH22056A
Other languages
English (en)
Inventor
Thomas Ken Schaaf
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PH15031A publication Critical patent/PH15031A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • C07D257/06—Five-membered rings with nitrogen atoms directly attached to the ring carbon atom

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PH22056A 1978-01-16 1979-01-12 N-(tetrazol-5-yl)prostaglandin carboxamides PH15031A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86956978A 1978-01-16 1978-01-16
US89373178A 1978-04-05 1978-04-05

Publications (1)

Publication Number Publication Date
PH15031A true PH15031A (en) 1982-05-13

Family

ID=27128123

Family Applications (3)

Application Number Title Priority Date Filing Date
PH22056A PH15031A (en) 1978-01-16 1979-01-12 N-(tetrazol-5-yl)prostaglandin carboxamides
PH23299A PH15653A (en) 1978-01-16 1979-11-19 N-(tetrazol-5-yl)prostaglandin carboxamides
PH23301A PH15643A (en) 1978-01-16 1979-11-19 N-(tetrazol-5-yl)prostaglandin carboxamides

Family Applications After (2)

Application Number Title Priority Date Filing Date
PH23299A PH15653A (en) 1978-01-16 1979-11-19 N-(tetrazol-5-yl)prostaglandin carboxamides
PH23301A PH15643A (en) 1978-01-16 1979-11-19 N-(tetrazol-5-yl)prostaglandin carboxamides

Country Status (28)

Country Link
JP (1) JPS54100378A (de)
AR (1) AR222817A1 (de)
AT (1) AT367755B (de)
AU (1) AU507853B2 (de)
CA (1) CA1152502A (de)
CH (1) CH635833A5 (de)
DD (1) DD141155A5 (de)
DE (1) DE2901476C3 (de)
DK (1) DK523378A (de)
ES (1) ES482421A1 (de)
FI (1) FI790120A (de)
FR (1) FR2414503A1 (de)
GB (1) GB2012272B (de)
GR (1) GR72747B (de)
IE (1) IE48175B1 (de)
IL (1) IL56433A (de)
IN (1) IN150279B (de)
IT (1) IT1110992B (de)
LU (1) LU80789A1 (de)
NL (1) NL7900292A (de)
NO (1) NO790122L (de)
NZ (1) NZ189377A (de)
PH (3) PH15031A (de)
PL (1) PL117869B1 (de)
PT (1) PT69076A (de)
SE (1) SE427657B (de)
SU (1) SU831071A3 (de)
YU (1) YU4579A (de)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE788209A (fr) * 1971-09-01 1973-02-28 Pfizer Derives tetrazoyliques des prostaglandines naturelles
DD118856A5 (de) * 1972-11-08 1976-03-20
IE43462B1 (en) * 1975-06-23 1981-03-11 Pfizer Substituted tetranorprostaglandins
DE2559093C3 (de) * 1975-12-30 1981-12-24 Pfizer Inc., 10017 New York, N.Y. 2-Desarboxy-2-[tetrazol-5-yl]-11-desoxy-ω-pentanorprostaglandine der E- oder F-Reihe und deren C↓15↓-Epimere
US4404372A (en) * 1977-06-13 1983-09-13 Pfizer Inc. 15-Substituted-ω-pentanorprostaglandin derivatives

Also Published As

Publication number Publication date
CA1152502A (en) 1983-08-23
NL7900292A (nl) 1979-07-18
FI790120A (fi) 1979-07-17
AT367755B (de) 1982-07-26
GB2012272A (en) 1979-07-25
PH15653A (en) 1983-03-11
IN150279B (de) 1982-09-04
IE790060L (en) 1979-07-16
DE2901476B2 (de) 1981-06-04
PT69076A (en) 1979-02-01
LU80789A1 (fr) 1980-08-08
AU507853B2 (en) 1980-02-28
DD141155A5 (de) 1980-04-16
IL56433A (en) 1982-04-30
PL117869B1 (en) 1981-08-31
YU4579A (en) 1983-01-21
IE48175B1 (en) 1984-10-17
DE2901476C3 (de) 1982-04-22
AU4335979A (en) 1979-07-26
PH15643A (en) 1983-03-11
SE427657B (sv) 1983-04-25
SU831071A3 (ru) 1981-05-15
ATA27579A (de) 1981-12-15
JPS54100378A (en) 1979-08-08
FR2414503A1 (fr) 1979-08-10
IT1110992B (it) 1986-01-13
ES482421A1 (es) 1980-04-01
GR72747B (de) 1983-12-02
NO790122L (no) 1979-07-17
GB2012272B (en) 1982-10-20
IT7919290A0 (it) 1979-01-15
PL212183A1 (de) 1980-02-11
IL56433A0 (en) 1979-03-12
FR2414503B1 (de) 1981-12-24
DK523378A (da) 1979-07-17
NZ189377A (en) 1981-05-15
AR222817A1 (es) 1981-06-30
DE2901476A1 (de) 1979-07-19
SE7900353L (sv) 1979-07-17
CH635833A5 (fr) 1983-04-29

Similar Documents

Publication Publication Date Title
NZ190589A (en) N-(heterocyclicaminocarbonyl)-arylsulphonamides
GB2020027B (en) Transducers
GB2013661B (en) 9-deoxy-9 -methylene isosteres of pgi2
GB2025974B (en) N-(diaminophosphinyl) carboxamides
JPS5587766A (en) 155deoxyy166hydroxyy166substituted prostanoic acids
GB2034903B (en) Transducer bridge amplifier
EP0062827A3 (en) Novel benzamide derivatives
IT1116868B (it) Procedimento per produrre cefalosporine
DE2960628D1 (en) Voltage-to-charge transducer
JPS54141751A (en) Prostaglandin anologues
AU527408B2 (en) N-(phenylcycloalkyl) acetamides
GB2031157B (en) Displacement transducer
GB2034555B (en) Bridge amplifier
GB2036984B (en) Transducers
PH15653A (en) N-(tetrazol-5-yl)prostaglandin carboxamides
ZA79149B (en) N-(tetrazol-5-yl)prostaglandin carboxamides
IT1162665B (it) Procedimento per ppeparare cefalosporine
JPS53135956A (en) 111deoxyyomegaapentanol prostaglandin
GB2016454B (en) N-(2-aminocycloheptyl) acylanilides
DE2967609D1 (en) Novel benzamide derivatives
BG28954A2 (en) Transducer for wavegraph
NZ186996A (en) N-(1h-tetrazol-5-yl)-quinolin-8-ylcarboxamides
NZ194253A (en) 9-deoxy-9a-methylene isosteres